` 1783 (Maxigen Biotech Inc) vs Taiwan Weighted Index Comparison - Alpha Spread

1783
vs
T
Taiwan Weighted Index

Over the past 12 months, Maxigen Biotech Inc has underperformed Taiwan Weighted Index, delivering a return of -10% compared to the Taiwan Weighted Index's +20% growth.

Stocks Performance
1783 vs Taiwan Weighted Index

Loading
1783
Taiwan Weighted Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1783 vs Taiwan Weighted Index

Loading
1783
Taiwan Weighted Index
Difference
www.alphaspread.com

Performance By Year
1783 vs Taiwan Weighted Index

Loading
1783
Taiwan Weighted Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Maxigen Biotech Inc vs Peers

Taiwan Weighted Index
1783
OR
ULVR
HINDUNILVR
HLN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Maxigen Biotech Inc
Glance View

Market Cap
3.8B TWD
Industry
Consumer products

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Intrinsic Value
39.61 TWD
Overvaluation 7%
Intrinsic Value
Price
Back to Top